EC approves imetelstat for transfusion-dependent anemia in lower-risk MDS
Researchers document peripheral T-cell lymphomas across Latin America
How do lifestyle factors play a role in the response to CAR-T therapy?
Patient case highlights secondary tumor after CAR-T treatment for myeloma
Olutasidenib plus azacitidine show ‘durable’ responses in relapsed or refractory IDH1-mutated AML

Join SOHO

Home
About
Society Updates
- Society Updates
- Join SOHO
Resources
News
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Roundtable Discussions
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

MDS News

Myelodysplastic Syndromes

EC approves imetelstat for transfusion-dependent anemia in lower-risk MDS

by Leah Sherwood
March 17, 2025
0 Comments

Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms News Society Updates

Abstract submissions now open for SOHO 2025

by Leah Sherwood
February 14, 2025
0 Comments

Leukemia Myelodysplastic Syndromes News

Is unrelated cord blood better than bone marrow in haploidentical transplantation?

by SOHO Insider Editors
February 4, 2025
0 Comments

Myelodysplastic Syndromes

Dr. Garcia-Manero discusses mature data on luspatercept’s efficacy in MDS

by Leah Sherwood
January 22, 2025
0 Comments

Acute Myeloid Leukemia Leukemia Myelodysplastic Syndromes News

FDA grants fast track designation to LYT-200 in AML

by Leah Sherwood
January 17, 2025
0 Comments

Leukemia Myelodysplastic Syndromes

FDA approves imatinib oral solution to treat leukemia, other cancers

by Leah Sherwood
January 4, 2025
0 Comments

Acute Myeloid Leukemia Leukemia Myelodysplastic Syndromes

NCI’s myeloMATCH pushes the envelope in myeloid leukemia care

by Leah Sherwood
January 3, 2025
0 Comments

Myelodysplastic Syndromes News

CHMP announces positive opinion for imetelstat in lower-risk MDS treatment

by SOHO Insider Editors
December 19, 2024
0 Comments

Myelodysplastic Syndromes News

FDA approves luspatercept in adult patients with low-risk MDS

by sohonews
November 14, 2024
0 Comments

Myelodysplastic Syndromes News

Primary analysis finds luspatercept reduces transfusion dependence in lower-risk MDS

by sohonews
November 14, 2024
0 Comments

1
2

POPULAR NEWS

Acute Myeloid Leukemia , Leukemia , Myelodysplastic Syndromes

NCI’s myeloMATCH pushes the envelope in myeloid leukemia care

January 3, 2025

66th American Society of Hematology Annual Meeting & Exposition , Leukemia

Asciminib benefit-risk profile bests other TKIs in CML

December 10, 2024

Aggressive B-Cell Lymphomas , Lymphoma , News

Presence of circulating lymphoma cells a significant adverse risk factor in DLBCL

January 9, 2025

Top Categories

Cellular Therapy

7

Leukemia

24

Lymphoma

21

Multiple Myeloma

17

Myelodysplastic Syndromes

11

Myeloproliferative Neoplasms

7

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

MDS News

EC approves imetelstat for transfusion-dependent anemia in lower-risk MDS

Abstract submissions now open for SOHO 2025

Is unrelated cord blood better than bone marrow in haploidentical transplantation?

Dr. Garcia-Manero discusses mature data on luspatercept’s efficacy in MDS

FDA grants fast track designation to LYT-200 in AML

FDA approves imatinib oral solution to treat leukemia, other cancers

NCI’s myeloMATCH pushes the envelope in myeloid leukemia care

CHMP announces positive opinion for imetelstat in lower-risk MDS treatment

FDA approves luspatercept in adult patients with low-risk MDS

Primary analysis finds luspatercept reduces transfusion dependence in lower-risk MDS

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Recent Posts

EC approves imetelstat for transfusion-dependent anemia in lower-risk MDS

Researchers document peripheral T-cell lymphomas across Latin America

How do lifestyle factors play a role in the response to CAR-T therapy?

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Follow Us

MDS News

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms